World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
22266
World Ranking
15742
National Ranking
33

Shing Jong Lin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Shing Jong Lin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 538 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Shing Jong Lin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Shing Jong Lin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Disease

Shing-Jong Lin mostly deals with Internal medicine, Endocrinology, Cardiology, Endothelial stem cell and Molecular biology. His research investigates the connection with Internal medicine and areas like Diabetes mellitus which intersect with concerns in Polymorphism. His Endocrinology research includes themes of Tube formation, Protein kinase A and C-reactive protein.

His work on Coronary artery disease and Heart failure as part of his general Cardiology study is frequently connected to Asymmetric dimethylarginine and In patient, thereby bridging the divide between different branches of science. Shing-Jong Lin interconnects Tumor necrosis factor alpha, Immunology, Cell adhesion molecule, Mitosis and Cell adhesion in the investigation of issues within Endothelial stem cell. His Molecular biology research integrates issues from Promoter, Mitogen-activated protein kinase, Catalase and Genotype.

His most cited work include:

  • Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients (277 citations)
  • High Glucose Impairs Early and Late Endothelial Progenitor Cells by Modifying Nitric Oxide–Related but Not Oxidative Stress–Mediated Mechanisms (261 citations)
  • Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure (181 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Internal medicine, Cardiology, Endocrinology, Coronary artery disease and Diabetes mellitus. His studies link Surgery with Internal medicine. In general Cardiology, his work in Heart failure, Percutaneous coronary intervention and Mace is often linked to In patient linking many areas of study.

His Endocrinology research is multidisciplinary, relying on both Progenitor cell, Endothelial stem cell and Endothelial progenitor cell. His Coronary artery disease research includes elements of C-reactive protein, Artery, Prospective cohort study and Endothelial dysfunction. His studies deal with areas such as Physical therapy, Incidence and Atrial fibrillation as well as Cohort.

He most often published in these fields:

  • Internal medicine (94.32%)
  • Cardiology (43.94%)
  • Endocrinology (30.87%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (94.32%)
  • Cardiology (43.94%)
  • Diabetes mellitus (14.39%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Cardiology, Diabetes mellitus, Coronary artery disease and Myocardial infarction. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Endocrinology. In general Endocrinology study, his work on Adiponectin and Oxidative stress often relates to the realm of Asymmetric dimethylarginine, thereby connecting several areas of interest.

His biological study spans a wide range of topics, including Stroke and Kidney disease. Shing-Jong Lin focuses mostly in the field of Diabetes mellitus, narrowing it down to topics relating to Surgery and, in certain cases, Type 2 Diabetes Mellitus. His Coronary artery disease study integrates concerns from other disciplines, such as Critical limb ischemia, Revascularization, Amputation, Prospective cohort study and Cohort.

Between 2016 and 2021, his most popular works were:

  • Statin Therapy Reduces Future Risk of Lower-Limb Amputation in Patients With Diabetes and Peripheral Artery Disease. (35 citations)
  • The 2017 focused update of the guidelines of the Taiwan society of cardiology (TSOC) and the Taiwan hypertension society (THS) for the management of hypertension (31 citations)
  • Imbalanced Production of Reactive Oxygen Species and Mitochondrial Antioxidant SOD2 in Fabry Disease-Specific Human Induced Pluripotent Stem Cell-Differentiated Vascular Endothelial Cells (23 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Surgery

His scientific interests lie mostly in Internal medicine, Diabetes mellitus, Cardiology, Myocardial infarction and Risk factor. His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Surgery. His Endocrinology research is multidisciplinary, incorporating perspectives in Acute kidney injury and Clinical significance.

The Diabetes mellitus study combines topics in areas such as Retrospective cohort study and Hazard ratio. His research brings together the fields of Cohort study and Cardiology. His Myocardial infarction study incorporates themes from Clinical endpoint and Cohort.

Best Publications

  • High Glucose Impairs Early and Late Endothelial Progenitor Cells by Modifying Nitric Oxide–Related but Not Oxidative Stress–Mediated Mechanisms

    Yung Hsiang Chen;Shing Jong Lin;Feng Yen Lin;Tao Cheng Wu

  • Systemic immune‐inflammation index (SII) predicted clinical outcome in patients with coronary artery disease

    Ya Ling Yang;Cheng Hsueh Wu;Pai Feng Hsu;Su Chan Chen

  • Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients

    Ying Hwa Chen;Shing Jong Lin;Ming Wei Lin;Hui Ling Tsai

  • Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure

    Wei Hsian Yin;Jaw-Wen Chen;Jaw-Wen Chen;Hsu Lung Jen;Meng Cheng Chiang

  • Effect of surface oxide properties on corrosion resistance of 316L stainless steel for biomedical applications

    Chun Che Shih;Chun Che Shih;Chun Ming Shih;Yea Yang Su;Lin Hui Julie Su

  • High incidence of the cardiac variant of fabry disease revealed by newborn screening in the Taiwan Chinese population

    Hsiang Yu Lin;Hsiang Yu Lin;Kah Wai Chong;Ju Hui Hsu;Hsiao Chi Yu

  • Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X

    Jaw Wen Chen;Nai Wei Hsu;Tao Cheng Wu;Shing Jong Lin

  • Diabetes Mellitus and the Risk of Alzheimer’s Disease: A Nationwide Population-Based Study

    Chin Chou Huang;Chia Min Chung;Hsin Bang Leu;Liang Yu Lin

  • Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.

    Tse Min Lu;Yu An Ding;Shing Jong Lin;Wen Shin Lee

  • The cytotoxicity of corrosion products of nitinol stent wire on cultured smooth muscle cells

    Chun Che Shih;Shing Jong Lin;Yuh Lien Chen;Yea Yang Su

  • Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation Meta-Analysis

    Kang-Ling Wang;Gregory Y.H. Lip;Shing-Jong Lin;Chern-En Chiang

  • Increase of Vitamin E Content in LDL and Reduction of Atherosclerosis in Cholesterol-Fed Rabbits by a Water-Soluble Antioxidant-Rich Fraction of Salvia miltiorrhiza

    Yih-Jer Wu;Chuang-Ye Hong;Shing-Jong Lin;Paulin Wu

  • Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells.

    Yung Hsiang Chen;Shing Jong Lin;Hung Hai Ku;Ming Shi Shiao

  • 2015 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension

    Chern En Chiang;Tzung Dau Wang;Kwo Chang Ueng;Tsung Hsien Lin

  • Arterial hemodynamics in human hypertension.

    C T Ting;K P Brin;S J Lin;S P Wang

  • Matrix Metalloproteinase-9 Is Essential for Ischemia-Induced Neovascularization by Modulating Bone Marrow–Derived Endothelial Progenitor Cells

    Po Hsun Huang;Yung Hsiang Chen;Chao Hung Wang;Jia Shiong Chen

  • Different effects of fosinopril and atenolol on wave reflections in hypertensive patients

    Chen Huan Chen;Chih Tai Ting;Shing Jong Lin;Tsui Lieh Hsu

  • Ginkgo biloba Extract Inhibits Tumor Necrosis Factor-α–Induced Reactive Oxygen Species Generation, Transcription Factor Activation, and Cell Adhesion Molecule Expression in Human Aortic Endothelial Cells

    Jaw Wen Chen;Yung Hsiang Chen;Feng Yan Lin;Yuh Lien Chen

  • Transendothelial transport of low density lipoprotein in association with cell mitosis in rat aorta.

    S J Lin;K M Jan;S Weinbaum;S Chien

  • Far Infrared Therapy Inhibits Vascular Endothelial Inflammation via the Induction of Heme Oxygenase-1

    Chih Ching Lin;Xiao Ming Liu;Kelly Peyton;Hong Wang

Frequent Co-Authors

Yuh-Lien Chen
Yuh-Lien Chen National Taiwan University
Tzeng-Ji Chen
Tzeng-Ji Chen Taipei Veterans General Hospital
Wen-Harn Pan
Wen-Harn Pan Academia Sinica
Shu Chien
Shu Chien University of California, San Diego
Pesus Chou
Pesus Chou National Yang Ming Chiao Tung University
Tzong-Shyuan Lee
Tzong-Shyuan Lee National Taiwan University
Roger J. Narayan
Roger J. Narayan North Carolina State University
Shih-Hwa Chiou
Shih-Hwa Chiou National Yang Ming Chiao Tung University
Yuan-Tsong Chen
Yuan-Tsong Chen Harbor–UCLA Medical Center
Shuen-Iu Hung
Shuen-Iu Hung National Yang Ming University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine offers a variety of rewarding career pathways beyond becoming a doctor. If you’re interested in leadership or administration, an affordable healthcare administration degree online can prepare you for roles managing hospitals, clinics, or health systems. Those seeking advanced credentials may consider the cheapest mha programs to boost their career prospects while minimizing student debt.

For nurses aiming for clinical leadership, the most affordable online dnp programs offer a pathway to the highest level of nursing practice. Meanwhile, students interested in pharmaceuticals or medication management can explore the 3 year online pharmd track for a flexible and accelerated route to becoming a pharmacist.

Exploring these related online degrees can open doors to diverse healthcare careers, accommodate busy schedules, and help reduce educational costs. Whether your goal is patient care, leadership, or research, these alternatives provide multiple ways to make a positive impact in the healthcare field.

Best Scientists Citing Shing Jong Lin

Trending Scientists

Recently Published Articles